The nuclear bile acid receptor FXR, strongly expressed in bowel and liver, is probably involved in NAFLD pathogenesis, by mediating control of lipids and glucose homeostasis, and controlling bacterial flora growth. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.